IMMUNOTHERAPY FOR PREVENTION AND TREATMENT OF TYPE-I DIABETES-MELLITUS

被引:0
|
作者
HELMKE, K
FEDERLIN, K
机构
来源
MUNCHENER MEDIZINISCHE WOCHENSCHRIFT | 1987年 / 129卷 / 44期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:796 / 799
页数:4
相关论文
共 50 条
  • [31] OPTIC NEUROPATHY IN TYPE-I DIABETES-MELLITUS
    HOMBERG, M
    TSCHOPE, D
    GREBER, H
    HACKLANDER, T
    SCHWIPPERT, B
    GRIES, FA
    MODDER, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1993, 118 (09) : 290 - 295
  • [32] PSYCHOSOMATIC THERAPY - TYPE-I DIABETES-MELLITUS
    SCHULERSCHNEIDER, A
    PRAXIS DER PSYCHOTHERAPIE UND PSYCHOSOMATIK, 1987, 32 (05) : 242 - 249
  • [33] ETIOLOGY AND COURSE OF TYPE-I DIABETES-MELLITUS
    RADDER, JK
    THOOLEN, IM
    VANGEMERT, GW
    DEJONGH, BM
    GEERTZEN, HGM
    NETHERLANDS JOURNAL OF MEDICINE, 1982, 25 (08): : 284 - 284
  • [34] CARDIOMYOPATHY IN CHILDHOOD TYPE-I DIABETES-MELLITUS
    HAUSDORF, G
    RIEGER, U
    KOEPP, P
    PEDIATRIC RESEARCH, 1987, 22 (02) : 218 - 218
  • [35] SERUM OSTEOCALCIN IN TYPE-I DIABETES-MELLITUS
    KRUSE, K
    KRACHT, U
    MONATSSCHRIFT KINDERHEILKUNDE, 1985, 133 (08) : 621 - 621
  • [36] EXPERIMENTAL IMMUNOPREVENTION OF TYPE-I DIABETES-MELLITUS
    BOITARD, C
    TIMSIT, J
    SEMPE, P
    BACH, JF
    DIABETES-METABOLISM REVIEWS, 1991, 7 (01): : 15 - 33
  • [37] EFFECTOR MECHANISMS IN TYPE-I DIABETES-MELLITUS
    NERUP, J
    MANDRUPPOULSEN, T
    MOLVIG, J
    ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY, 1986, D137 (03): : 463 - 468
  • [38] ADRENAL MEDULLITIS IN TYPE-I DIABETES-MELLITUS
    BROWN, FM
    SMITH, AM
    LONGWAY, S
    RABINOWE, SL
    CLINICAL RESEARCH, 1990, 38 (02): : A526 - A526
  • [39] EXTREME HYPERLIPIDEMIA IN TYPE-I DIABETES-MELLITUS
    PONDER, SW
    ELERIAN, L
    TRAVIS, LB
    CLINICAL PEDIATRICS, 1993, 32 (06) : 375 - 376
  • [40] TREATMENT OF TYPE-I DIABETES-MELLITUS WITH INTRACEREBRAL PANCREAS ISLET TRANSPLANT
    DONG, YH
    QIAN, J
    WANG, SY
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1991, 49 (01): : 74 - 80